US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 32.040
  • -0.170-0.53%
Close Apr 26 16:00 ET
  • 32.040
  • 0.0000.00%
Post 17:32 ET
1.19BMarket Cap-6935P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-32.42%17.45M
30.76%13.08M
1.87M
0
363.82%2.5M
-54.73%25.82M
2,858.58%10M
0
-30.61%15.28M
-98.39%539K
Operating revenue
-32.42%17.45M
30.76%13.08M
--1.87M
--0
363.82%2.5M
-54.73%25.82M
2,858.58%10M
--0
-30.61%15.28M
-98.39%539K
Cost of revenue
66.81%1.59M
204.00%1.22M
377K
0
0
-53.98%955K
1,766.67%400K
0
-29.17%522K
-97.46%33K
Gross profit
-36.23%15.85M
23.54%11.86M
1.49M
0
394.07%2.5M
-54.76%24.86M
2,551.93%9.6M
0
-30.66%14.76M
-98.43%506K
Operating expense
81.58%159.01M
128.34%56.31M
85.23%42.43M
64.28%32.82M
37.07%27.45M
30.49%87.57M
66.52%24.66M
35.70%22.91M
42.73%19.98M
-6.51%20.03M
Selling and administrative expenses
141.83%108.7M
193.89%43.01M
152.83%30.32M
95.40%20.28M
89.98%15.1M
76.99%44.95M
116.08%14.63M
79.79%11.99M
52.72%10.38M
53.99%7.95M
Research and development costs
18.04%50.31M
32.68%13.31M
10.93%12.11M
30.65%12.55M
2.28%12.36M
2.19%42.62M
24.76%10.03M
6.89%10.91M
33.30%9.6M
-25.71%12.08M
Operating profit
-128.28%-143.16M
-195.13%-44.45M
-78.71%-40.94M
-528.27%-32.82M
-27.82%-24.95M
-415.85%-62.71M
-4.24%-15.06M
-45.85%-22.91M
-171.74%-5.22M
-282.20%-19.52M
Net non-operating interest income expense
437.77%6.99M
38.61%1.99M
363.08%1.98M
671.26%1.41M
609.18%1.61M
3,511.11%1.3M
11,858.33%1.44M
5,250.00%428K
-3,628.57%-247K
-3,611.11%-316K
Non-operating interest income
195.43%10.34M
40.01%2.98M
167.67%2.84M
649.49%2.23M
--2.29M
9,619.44%3.5M
17,625.00%2.13M
13,162.50%1.06M
--297K
--0
Non-operating interest expense
56.25%3.23M
44.71%958K
40.55%825K
49.82%815K
116.46%684K
--2.06M
--662K
--587K
--544K
--316K
Total other finance cost
-10.37%121K
3.33%31K
-28.26%33K
----
----
--135K
--30K
--46K
----
----
Other net income (expense)
140.12%274K
1,970.37%559K
-413.16%-195K
94.85%-14K
81.00%-76K
58.63%-683K
107.48%27K
88.86%-38K
70.27%-272K
-1,076.47%-400K
Gain on sale of security
148.89%376K
642.86%572K
-374.19%-147K
108.73%33K
81.24%-82K
51.27%-769K
121.63%77K
91.04%-31K
56.85%-378K
---437K
Other non- operating income (expenses)
-218.60%-102K
74.00%-13K
-585.71%-48K
-144.34%-47K
-83.78%6K
217.81%86K
-900.00%-50K
-240.00%-7K
371.79%106K
208.82%37K
Income before tax
-118.85%-135.89M
-208.13%-41.9M
-73.87%-39.15M
-447.17%-31.42M
-15.72%-23.42M
-350.88%-62.1M
8.10%-13.6M
-40.39%-22.52M
-190.10%-5.74M
-289.33%-20.24M
Income tax
0
0
0
0
0
-107.27%-4K
0
98.53%-5K
0
-99.68%1K
Net income
-118.86%-135.89M
-208.13%-41.9M
-73.91%-39.15M
-447.17%-31.42M
-15.72%-23.42M
-349.06%-62.09M
8.43%-13.6M
-43.41%-22.51M
-190.51%-5.74M
-295.05%-20.24M
Net income continuous Operations
-118.86%-135.89M
-208.13%-41.9M
-73.91%-39.15M
-447.17%-31.42M
-15.72%-23.42M
-349.06%-62.09M
8.43%-13.6M
-43.41%-22.51M
-190.51%-5.74M
-295.05%-20.24M
Minority interest income
Net income attributable to the parent company
-118.86%-135.89M
-208.13%-41.9M
-73.91%-39.15M
-447.17%-31.42M
-15.72%-23.42M
-349.06%-62.09M
8.43%-13.6M
-43.41%-22.51M
-190.51%-5.74M
-295.05%-20.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-118.86%-135.89M
-208.13%-41.9M
-73.91%-39.15M
-447.17%-31.42M
-15.72%-23.42M
-349.06%-62.09M
8.39%-13.6M
-43.41%-22.51M
-191.17%-5.74M
-296.75%-20.24M
Basic earnings per share
-83.33%-4.62
-167.35%-1.31
-52.38%-1.28
-387.50%-1.17
10.20%-0.88
-276.12%-2.52
31.94%-0.49
-10.53%-0.84
-177.42%-0.24
-292.16%-0.98
Diluted earnings per share
-83.33%-4.62
-167.35%-1.31
-51.61%-1.28
-387.50%-1.17
10.20%-0.88
-276.12%-2.52
31.94%-0.49
-11.09%-0.8443
-182.76%-0.24
-308.51%-0.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -32.42%17.45M30.76%13.08M1.87M0363.82%2.5M-54.73%25.82M2,858.58%10M0-30.61%15.28M-98.39%539K
Operating revenue -32.42%17.45M30.76%13.08M--1.87M--0363.82%2.5M-54.73%25.82M2,858.58%10M--0-30.61%15.28M-98.39%539K
Cost of revenue 66.81%1.59M204.00%1.22M377K00-53.98%955K1,766.67%400K0-29.17%522K-97.46%33K
Gross profit -36.23%15.85M23.54%11.86M1.49M0394.07%2.5M-54.76%24.86M2,551.93%9.6M0-30.66%14.76M-98.43%506K
Operating expense 81.58%159.01M128.34%56.31M85.23%42.43M64.28%32.82M37.07%27.45M30.49%87.57M66.52%24.66M35.70%22.91M42.73%19.98M-6.51%20.03M
Selling and administrative expenses 141.83%108.7M193.89%43.01M152.83%30.32M95.40%20.28M89.98%15.1M76.99%44.95M116.08%14.63M79.79%11.99M52.72%10.38M53.99%7.95M
Research and development costs 18.04%50.31M32.68%13.31M10.93%12.11M30.65%12.55M2.28%12.36M2.19%42.62M24.76%10.03M6.89%10.91M33.30%9.6M-25.71%12.08M
Operating profit -128.28%-143.16M-195.13%-44.45M-78.71%-40.94M-528.27%-32.82M-27.82%-24.95M-415.85%-62.71M-4.24%-15.06M-45.85%-22.91M-171.74%-5.22M-282.20%-19.52M
Net non-operating interest income expense 437.77%6.99M38.61%1.99M363.08%1.98M671.26%1.41M609.18%1.61M3,511.11%1.3M11,858.33%1.44M5,250.00%428K-3,628.57%-247K-3,611.11%-316K
Non-operating interest income 195.43%10.34M40.01%2.98M167.67%2.84M649.49%2.23M--2.29M9,619.44%3.5M17,625.00%2.13M13,162.50%1.06M--297K--0
Non-operating interest expense 56.25%3.23M44.71%958K40.55%825K49.82%815K116.46%684K--2.06M--662K--587K--544K--316K
Total other finance cost -10.37%121K3.33%31K-28.26%33K----------135K--30K--46K--------
Other net income (expense) 140.12%274K1,970.37%559K-413.16%-195K94.85%-14K81.00%-76K58.63%-683K107.48%27K88.86%-38K70.27%-272K-1,076.47%-400K
Gain on sale of security 148.89%376K642.86%572K-374.19%-147K108.73%33K81.24%-82K51.27%-769K121.63%77K91.04%-31K56.85%-378K---437K
Other non- operating income (expenses) -218.60%-102K74.00%-13K-585.71%-48K-144.34%-47K-83.78%6K217.81%86K-900.00%-50K-240.00%-7K371.79%106K208.82%37K
Income before tax -118.85%-135.89M-208.13%-41.9M-73.87%-39.15M-447.17%-31.42M-15.72%-23.42M-350.88%-62.1M8.10%-13.6M-40.39%-22.52M-190.10%-5.74M-289.33%-20.24M
Income tax 00000-107.27%-4K098.53%-5K0-99.68%1K
Net income -118.86%-135.89M-208.13%-41.9M-73.91%-39.15M-447.17%-31.42M-15.72%-23.42M-349.06%-62.09M8.43%-13.6M-43.41%-22.51M-190.51%-5.74M-295.05%-20.24M
Net income continuous Operations -118.86%-135.89M-208.13%-41.9M-73.91%-39.15M-447.17%-31.42M-15.72%-23.42M-349.06%-62.09M8.43%-13.6M-43.41%-22.51M-190.51%-5.74M-295.05%-20.24M
Minority interest income
Net income attributable to the parent company -118.86%-135.89M-208.13%-41.9M-73.91%-39.15M-447.17%-31.42M-15.72%-23.42M-349.06%-62.09M8.43%-13.6M-43.41%-22.51M-190.51%-5.74M-295.05%-20.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -118.86%-135.89M-208.13%-41.9M-73.91%-39.15M-447.17%-31.42M-15.72%-23.42M-349.06%-62.09M8.39%-13.6M-43.41%-22.51M-191.17%-5.74M-296.75%-20.24M
Basic earnings per share -83.33%-4.62-167.35%-1.31-52.38%-1.28-387.50%-1.1710.20%-0.88-276.12%-2.5231.94%-0.49-10.53%-0.84-177.42%-0.24-292.16%-0.98
Diluted earnings per share -83.33%-4.62-167.35%-1.31-51.61%-1.28-387.50%-1.1710.20%-0.88-276.12%-2.5231.94%-0.49-11.09%-0.8443-182.76%-0.24-308.51%-0.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg